A new research study by Fact.MR projects that the global syndesmosis implant system market is on track to reach a value of US$ 98.6 million in 2024, with an anticipated growth rate of 8.2% CAGR from 2024 to 2034. The rising popularity of bioabsorbable implants, due to their unique advantages for patients, is a key driver of this market expansion.
Bioabsorbable implants are designed to gradually dissolve within the body after stabilizing the surgical site, eliminating the need for a second surgery to remove the implant. This feature significantly reduces overall healthcare costs, minimizes surgical risks, and shortens patient recovery times. As a result, both patients and medical professionals increasingly favor these implants, leading to their growing use in orthopedic treatments.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10206
Key Market Insights
Global Growth: The syndesmosis implant system market is expected to reach US$ 217.3 million by 2034.
Titanium-Based Implants: Sales of titanium-based plate implants are projected to reach US$ 117 million by 2034.
North America: The region is set to account for 43% of the global market share in 2024, with the U.S. market alone estimated to reach US$ 87 million by 2034.
Japan: The market in Japan is expected to grow from US$ 5.63 million in 2024 to US$ 13.28 million by 2034.
Canada: The Canadian market is forecasted to expand at a CAGR of 6.9% through 2034.
Application Segments: The ankle fractures segment is poised to hold 55% of the market share in 2024.
End Users: Ambulatory settings are expected to generate revenue worth US$ 122.8 million by the end of 2034.
Leading companies in the syndesmosis implant system market include Smith & Nephew, Acumed LLC, Mortis Medical, Exactech, Arthrex, Inc., Wright Medical Group N.V., Zimmer Biomet, Paragon 28, Inc., Stryker Corporation, and Inion OY.
Regional Highlights
North America: By 2024, North America is predicted to hold a 43% share of the global syndesmosis implant system market. The region’s high prevalence of sports-related injuries, particularly ankle injuries, is a significant market driver. As a result, there is a growing need for effective implant systems that support quick recovery and return to normal activities.
East Asia: The bioabsorbable implant market in East Asia is projected to grow at a CAGR of 8.8% from 2024 to 2034, driven by the region’s increasing incidence of orthopedic problems.
Japan: The advanced healthcare system in Japan is contributing to the growth of the syndesmosis implant market. Japanese medical professionals use state-of-the-art facilities to perform modern orthopedic treatments, including syndesmosis implants, providing patients with more treatment options and improved care.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=10206
Demand for Titanium-Based Implants
Titanium-based plate implants are increasingly preferred due to their superior strength, corrosion resistance, and biocompatibility. These implants provide excellent stability and support for fractured or damaged bones, while reducing the risk of adverse reactions or complications. Their widespread use in orthopedic procedures makes titanium-based implants a top choice among patients and healthcare providers.
Additional Insights
The report offers insights into various market segments, including product type (titanium-based plate implants, stainless steel-based plate implants, biodegradable material-based implants), application (ankle fractures, syndesmosis reduction, postoperative management), and end user (hospitals, ambulatory settings, specialized orthopedic clinics) across seven major regions: North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and MEA.